Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  PCAS    PCA   FR0000053514


Delayed Quote. Delayed  - 02/08 11:35:29 am
7.61 EUR   -1.93%
02/02 PCAS : 2015 sales - strong growth
2015 PCAS : Sales as of 30 september 2015, +4.8 % growth
2015 PCAS : ADEME acquires a stake in ENERSENS
News SummaryMost relevantAll newsSector news 

PCAS : quarterly financial reporting Sep 30, 2011

10/07/2011 | 11:40am US/Eastern

Quarterly financial reporting
As of 30 September 2011



Business update


(in thousands of euros)20112010% change
 First Quarter44,05341,4346,3%
 including Pharmaceutical Synthesis27,14726,6032,0%
 including Specialty Chemicals16,90614,83114,0%
 Second Quarter41,78942,698-2,1%
 including Pharmaceutical Synthesis26,45728,100-5,8%
 including Specialty Chemicals15,33214,5985,0%
 Third Quarter33,48133,658-0,5%
 including Pharmaceutical Synthesis19,53018,3946,2%
 including Specialty Chemicals13,95115,264-8,6%
 Total as of 30 September119,323117,7901,3%
 including Pharmaceutical Synthesis73,13473,0970,1%
 including Specialty Chemicals46,18944,6933,3%




The PCAS Group's consolidated revenues at 30 September 2011came in 1.3% higher than the same period the previous year.


Pharmaceutical Synthesis
Over the first five months of the year, business was affected by the planned reduction in the contribution by the new contract between PCAS and Sanofi, effective since 31 May 2010. Excluding this contract, the Exclusive and Non-Exclusive Pharma business is up 10.5% at 30 September 2011.
Fine Specialty Chemicals
With growth of 3.3% at 30 September 2011, the Fine Specialty Chemicals business contracted by 8.6% during the third quarter of 2011 in relation to 2010, reflecting the economic slowdown seen since the summer.


Key operations and events for the quarter


No important events likely to have a significant impact on the company's business or situation occurred during the third quarter of 2011.


Outlook for the current year


The high level of sales expected for the fourth quarter should lead to earnings growth in 2011.



Next date :  2011 earnings, February 22nd, 2012



About PCAS
PCAS is a fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability.


Longjumeau, October 7th, 2011



This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: PCAS via Thomson Reuters ONE

React to this article
Latest news on PCAS
02/02 PCAS : 2015 sales - strong growth
2015 PCAS : Sales as of 30 september 2015, +4.8 % growth
2015 PCAS : ADEME acquires a stake in ENERSENS
2015 PCAS : Ademe acquires a stake in enersens as part of the 'investments for the fu..
2015 PCAS : ex-dividend day for interim dividend
2015 PCAS : 2015 HYR - Very good operational performance Pharma focus yields strong g..
2015 PCAS : Sustained growth in net sales for the first half of 2015
2015 PCAS : Participation de PCAS au Forum d’affaires France-Chine à Paris le 1..
2015 PCAS : takes part in the China-France Business Forum held in Paris on July 1st, ..
2015 PCAS : reinforces its management team and hires several new staff members within..
News chart
Full-screen chart
Income Statement Evolution
More Financials